IDYA
Price
$26.65
Change
+$0.96 (+3.74%)
Updated
Sep 26, 01:13 PM (EDT)
Capitalization
2.25B
46 days until earnings call
IMCR
Price
$34.59
Change
+$0.51 (+1.50%)
Updated
Sep 26, 01:07 PM (EDT)
Capitalization
1.72B
40 days until earnings call
Interact to see
Advertisement

IDYA vs IMCR

Header iconIDYA vs IMCR Comparison
Open Charts IDYA vs IMCRBanner chart's image
IDEAYA Biosciences
Price$26.65
Change+$0.96 (+3.74%)
Volume$444
Capitalization2.25B
Immunocore Holdings
Price$34.59
Change+$0.51 (+1.50%)
Volume$749
Capitalization1.72B
IDYA vs IMCR Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. IMCR commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and IMCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IDYA: $25.69 vs. IMCR: $34.08)
Brand notoriety: IDYA and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 136% vs. IMCR: 118%
Market capitalization -- IDYA: $2.25B vs. IMCR: $1.72B
IDYA [@Biotechnology] is valued at $2.25B. IMCR’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCR is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while IMCR’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • IMCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than IMCR.

Price Growth

IDYA (@Biotechnology) experienced а -2.02% price change this week, while IMCR (@Biotechnology) price change was +1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

IMCR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.25B) has a higher market cap than IMCR($1.72B). IMCR YTD gains are higher at: 15.525 vs. IDYA (-0.039). IMCR has higher annual earnings (EBITDA): -1.31M vs. IDYA (-380.2M). IMCR has more cash in the bank: 883M vs. IDYA (670M). IDYA has less debt than IMCR: IDYA (26.6M) vs IMCR (436M). IMCR has higher revenues than IDYA: IMCR (356M) vs IDYA (7M).
IDYAIMCRIDYA / IMCR
Capitalization2.25B1.72B131%
EBITDA-380.2M-1.31M28,979%
Gain YTD-0.03915.525-0%
P/E RatioN/AN/A-
Revenue7M356M2%
Total Cash670M883M76%
Total Debt26.6M436M6%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIMCR
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TAMVX32.97N/A
N/A
T. Rowe Price Mid-Cap Value Adv
FBSIX38.98N/A
N/A
Franklin Mutual U.S. Mid Cap Value R6
SMUYX10.10N/A
N/A
SEI Multi-Strategy Alternative Y (SIMT)
PINDX21.84N/A
N/A
Victory Pioneer Disciplined Growth A
LIGNX12.05N/A
N/A
Loomis Sayles International Growth N

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.08%
IMNM - IDYA
60%
Loosely correlated
-9.33%
SYRE - IDYA
58%
Loosely correlated
-8.18%
NRIX - IDYA
58%
Loosely correlated
-4.25%
CGON - IDYA
57%
Loosely correlated
-0.55%
XENE - IDYA
57%
Loosely correlated
-0.19%
More

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with NUVL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-0.55%
NUVL - IMCR
51%
Loosely correlated
-2.54%
NRIX - IMCR
51%
Loosely correlated
-4.25%
IMVT - IMCR
46%
Loosely correlated
+1.36%
IDYA - IMCR
46%
Loosely correlated
+0.08%
ROIV - IMCR
46%
Loosely correlated
+1.77%
More